Dr. Anjali Pandey has led medicinal chemistry at Sudo Biosciences since its founding in 2020. She is an executive biopharmaceutical R&D leader with 25+ years of experience and expertise in all stages of discovery and development from initial lead identification through approval.
Current role
Head of Medicinal Chemistry & Discovery Funding at Metrion Biosciences
Head of Medicinal Chemistry at Oblique Therapeutics
Head of Medicinal Chemistry at Rewind Therapeutics
Head of Medicinal Chemistry at Augustine Therapeutics
Head of Medicinal Chemistry at Ermium Therapeutics